A team of researchers from the University of Chicago's Pritzker School of Molecular Engineering (UChicago PME) has used ...

A new AI model designs peptides (short proteins) that are targeted by enzymes called proteases, which are overactive in cancer cells. Nanoparticles coated with these peptides can act as sensors that ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022, with ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

Skin cancer is the most commonly diagnosed cancer in the United States, affecting one in five Americans during their lifetime. While basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) ...

Mainz Biomed N.V. has announced the next phase in its PancAlert project, which aims to develop a non-invasive blood test for early pancreatic cancer detection. Following a successful discovery ...

SpotitEarly, a biotech startup that uses AI and dogs to detect cancer using an at-home test, announced its launch into the U.S. market with $20.3 million in funding. The company has received funding ...

Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following ...

Under the old guidelines, women were assessed for ovarian cancer if their CA125 levels in blood tests reached or exceeded 35 IU/mL, regardless of age. But CA125 is not an accurate predictor of ovarian ...